Vontobel Holding Ltd.,
Strategic Blueprint LLC, and
Mutual Advisors LLC have sold a significant number of shares of
Danaher Corporation (DHR). This is in contrast to various big names like
Bank of New York Mellon Corp and
Principal Financial Group Inc. that have increased their positions in the corporation.
Jim Cramer, the American television personality, commentator, and former hedge fund manager, has also suggested that Danaher can make a comeback. The company's cost cuts, biotech momentum, and valuation re-rating were underlined as potential drivers of upside. Despite selloffs by some entities, others have speculated about Danaher's potential in
next-gen precision medicine tests through a partnership with
AstraZeneca PLC. Danaher's financial results for Q2 2025 are shortly to be released.
Danaher Corporation DHR News Analytics from Fri, 07 Mar 2025 08:00:00 GMT to Sat, 05 Jul 2025 18:46:03 GMT -
Rating 6
- Innovation 7
- Information 5
- Rumor 2
